Skip to content
Open access

Effects of Bauhinia purpurea leaf extracts on cytotoxicity and CCND1 gene expression in MCF-7 cells

Aug 2026 · Natural Resources for Human Health · 0 citations · 32 references

TL;DR

Bauhinia purpurea leaf extracts showed solvent-dependent cytotoxicity and downregulated CCND1 gene expression comparable to doxorubicin, highlighting its potential as a phytopharmaceutical for breast cancer therapy via cell cycle inhibition.

Abstract

Background: Breast cancer ranks as a major cause of cancer-related mortality among women worldwide, with CCND1 (Cyclin D1) gene overexpression contributing significantly to disease progression. Bauhinia purpurea, a medicinal plant rich in bioactive compounds, has shown antioxidant, hepatoprotective, hypoglycemic, and antiproliferative properties, highlighting its potential as an anticancer agent. Methods: This study assessed the cytotoxic potential and modulation of CCND1 gene expression by B. purpurea leaf extracts obtained using 96% ethanol, ethyl acetate, and n-hexane, tested in vitro on MCF-7 breast cancer cells. Cytotoxicity was measured through the MTT assay following 48 h of treatment, while CCND1 expression levels were analyzed via qRT-PCR with GAPDH as the internal control. Results: Phytochemical analysis identified flavonoids, tannins, polyphenols, steroids/triterpenoids, and alkaloids within the extracts. After 48 h, the MTT assay indicated that the ethyl acetate fraction exhibited moderate cytotoxicity (IC50 = 88.5 μg/mL), the n-hexane fraction showed weak cytotoxicity (IC50 = 271.8 μg/mL), and the ethanol fraction displayed no cytotoxic effect (IC50 = 979.99 μg/mL). Gene expression analysis showed that all extracts significantly reduced CCND1 levels at IC25, IC50, and IC75, with effects comparable to doxorubicin (p < 0.05). Conclusion: Bauhinia purpurea leaf extracts showed solvent-dependent cytotoxicity and downregulated CCND1 gene expression comparable to doxorubicin, highlighting its potential as a phytopharmaceutical for breast cancer therapy via cell cycle inhibition.

Read PDF

Similar papers

Open access Aug 2026

Phytochemical Characterisation and In Vitro Anticancer Potential of Combretum indicum Leaf Aqueous Extract Against A549 Cells

The aqueous leaf extract of C. indicum demonstrated promising antioxidant and anti-cancer potential and stigmasterol emerged as the most promising lead phytoconstituent against EGFR, ALK, ROS1, PI3K, and MET.

A. Sundararajan, C. Loganathan, J. Angayarkanni · 0 citations
Open access Sep 2026

Evaluation of Prunus africana Bark Extract-Induced Apoptotic Activities and Associated Signaling Pathways in Selected Breast Cancer Cells

Findings highlight the therapeutic potential of P. africana, particularly the EtOH-100 extract, as a viable treatment for TNBC and suggest modulation of oncogenic signaling.

Lucy T. Ebini, Karl E. Miletti-González, Cecile T. Ojong et al. · 0 citations
Open access Oct 2026

A Preliminary Investigation of Stachys subnuda's Anticancer Effects on the MCF-7 Breast Cancer Cell Line

Objective: Stachys subnuda, traditionally used in Anatolia for various ailments, is a medicinal plant with known therapeutic potential. Previous studies have already demonstrated the antioxidant and anti-inflammatory properties of Stachys species. Since the major secondary metabolites of Stachys subnuda are known to po...

İrem Atlıhan, Sevgi Koçyiğit Sevinç, Goksel Arda Tiber et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.